MedPath

Ilioinguinal Nerve Block With Local Anesthetic vs. Placebo in Inguinal Hernia Repair Under Spinal Anesthesia

Not Applicable
Active, not recruiting
Conditions
Inguinal Hernias
Interventions
Drug: Ilioinguinal/iliohypogastric Nerve Block
Other: Ilioinguinal/iliohypogastric with Placebo Block
Registration Number
NCT07049835
Lead Sponsor
Makassed General Hospital
Brief Summary

Postoperative pain management remains a critical area of concern in surgical practices, especially in procedures involving the lower abdomen and pelvis. Inguinal Hernia is considered among few surgeries that may lead to chronic pain. Spinal anesthesia is a commonly utilized modality because of its efficacy in pain control and rapid recovery. However, the addition of peripheral nerve blocks, such as the ilioinguinal nerve block, may provide enhanced pain relief and reduce opioid consumption postoperatively. This study aims to evaluate the effectiveness of spinal anesthesia alone compared to spinal anesthesia supplemented with ultrasound-guided ilioinguinal and iliohypo-gastric nerve block in managing postoperative pain.

Detailed Description

Objectives

1. Primary Objective: To compare the postoperative pain scores (using a standardized numerical rating scale) between patients receiving spinal anesthesia alone and those receiving spinal anesthesia with ultrasound-guided ilioinguinal nerve block.

2. Secondary Objectives:

* To assess the total opioid consumption in the first 24 hours post-surgery.

* To evaluate the time to first analgesic request postoperatively.

* Patient Satisfaction score post-op \>\> at rest , coughing , ambulation ( LEKENT SCORE ) .

Hypotheses

* Hypothesis 1: Patients receiving spinal anesthesia with an ilioinguinal nerve block will experience significantly lower postoperative pain scores compared to those receiving spinal anesthesia alone.

* Hypothesis 2: Patients receiving spinal anesthesia with an ilioinguinal nerve block will require less opioid medication in the first 24 hours post-surgery.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adults aged 18-65 years
  • ASA physical status I-III
  • Scheduled for elective lower abdominal surgery (e.g., inguinal hernia repair, cesarean section)
Exclusion Criteria
  • Allergy to local anesthetics
  • Coagulation disorders
  • Infection at the injection site
  • Patients with neurological conditions affecting lower limbs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intrathecal Mixture BlockIlioinguinal/iliohypogastric Nerve Block15cc 0.25% of Bupivacaine + Dexamethasone 8 mg 2cc
Intrathecal PlaceboIlioinguinal/iliohypogastric with Placebo Block17 cc of Ns/s
Primary Outcome Measures
NameTimeMethod
Postoperative pain management24 hours

Pain scores will be assessed using an 11-point numerical rating scale (0-10) at 1, 6, 12, and 24 hours postoperatively.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Makassed General Hospital

🇱🇧

Beirut, Lebanon

Makassed General Hospital
🇱🇧Beirut, Lebanon

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.